Does SARILUMAB Cause C-reactive protein increased? 644 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 644 reports of C-reactive protein increased have been filed in association with SARILUMAB (KEVZARA). This represents 3.0% of all adverse event reports for SARILUMAB.
644
Reports of C-reactive protein increased with SARILUMAB
3.0%
of all SARILUMAB reports
515
Deaths
500
Hospitalizations
How Dangerous Is C-reactive protein increased From SARILUMAB?
Of the 644 reports, 515 (80.0%) resulted in death, 500 (77.6%) required hospitalization, and 447 (69.4%) were considered life-threatening.
Is C-reactive protein increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SARILUMAB. However, 644 reports have been filed with the FAERS database.
What Other Side Effects Does SARILUMAB Cause?
Drug ineffective (5,065)
Pain (4,833)
Arthralgia (4,139)
Rheumatoid arthritis (3,963)
Joint swelling (3,951)
Condition aggravated (3,247)
Fatigue (3,000)
Rash (2,912)
Alopecia (2,660)
Abdominal discomfort (2,600)
What Other Drugs Cause C-reactive protein increased?
METHOTREXATE (5,999)
ADALIMUMAB (4,579)
RITUXIMAB (4,060)
ETANERCEPT (3,922)
TOCILIZUMAB (3,719)
INFLIXIMAB (3,621)
LEFLUNOMIDE (3,574)
HYDROXYCHLOROQUINE (3,552)
ABATACEPT (3,451)
SULFASALAZINE (3,096)
Which SARILUMAB Alternatives Have Lower C-reactive protein increased Risk?
SARILUMAB vs SATRALIZUMAB
SARILUMAB vs SATRALIZUMAB-MWGE
SARILUMAB vs SAXAGLIPTIN
SARILUMAB vs SCHOLL'S INGROWN TOENAIL PAIN RELIEVER
SARILUMAB vs SCOPOLAMINE